Related Experiment Video
Updated: Oct 3, 2026
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications
Marcela V Karpuj1, Mark W Becher, Lawrence Steinman
1Department of Neurological Sciences, Beckman Center for Molecular Medicine, B002, Stanford University, Stanford, CA 94305, USA.
Abstract:
Transglutaminase (TGase) activity is increased in affected regions of brains from patients with Huntington's disease (HD). TGase activity is particularly elevated in the nucleus compared with the cytoplasm from these brains. Gamma-glutaminyl-lysyl cross-links have been detected in nuclear inclusions in HD brain, indicating that TGase may play a prominent role in the aggregation of huntingtin (htt). Attempts to ameliorate experimental disease, via inhibition of TGase in transgenic models of HD in mice, are under investigation.
